Your Filters

Search Results

Showing 1-10 of 125 results for noncommunicable disease

Sort by Items Per Page
News Release

Noncommunicable Diseases in Developing Countries Emerging As a Global Health Crisis, Warns CFR Task Force

Rates of heart disease, cancer, diabetes, and other noncommunicable diseases (NCDs) in low- and middle-income countries are increasing faster, in younger people, and with worse outcomes than in wealthier countries. In 2013 alone, NCDs killed eight million people before their sixtieth birthdays in developing countries. A newA CFR-sponsored Independent Task Force reportA andA accompanying interactiveA look at the factors behind this epidemic and the ways the United States can best fight it.

The Global Health Crisis of Noncommunicable Diseases

with Thomas J. Bollyky, Maria Casa
Thomas J. Bollyky, CFRa's senior fellow for global health, economics, and development, discusses the global rise of noncommunicable diseases,A as part of CFR's Academic Conference Call series.
Other Report

New, Cheap, and Improved: Assessing the Promise of Reverse and Frugal Innovation to Address Noncommunicable Diseases

by Thomas J. Bollyky
In recent years, frugal and reverse innovation have gained attention as potential strategies for increasing the quality and accessibility of health care while slowing the growth in its costs. Thomas J. Bollyky arges that the demand for these types of innovation is increasing and outlinesA three practical questions for policymakers seeking real investments and results.

Understanding The Relationships Between Noncommunicable Diseases, Unhealthy Lifestyles, And Country Wealth

by Thomas J. Bollyky, Caroline Andridge, Joseph L. Dieleman
The amount of international aid given to address noncommunicable diseases is minimal. Most of it is directed to wealthier countries and focuses on the prevention of unhealthy lifestyles. Explanations for the current direction of noncommunicable disease aid include that these are diseases of affluence that benefit from substantial research and development into their treatment in high-income countries and are better addressed through domestic tax and policy measures to reduce risk-factor prevalence than through aid programs. This study assessed these justifications. First, we examined the relationships among premature adult mortality, defined as the probability that a person who has lived to the age of fifteen will die before the age of sixty from noncommunicable diseases; the major risk factors for these diseases; and country wealth. Second, we compared noncommunicable and communicable diseases prevalent in poor and wealthy countries alike, and their respective links to economic development. Last, we examined the respective roles that wealth and risk prevention have played in countries that achieved substantial reductions in premature mortality from noncommunicable diseases. Our results support greater investment in cost-effective noncommunicable disease preventive care and treatment in poorer countries and a higher priority for reducing key risk factors, particularly tobacco use.

Noncommunicable Diseases in the Developing World

Thomas J. Bollyky, CFR's senior fellow for global health, economics, and development, leads a discussion on the rise of noncommunicable diseases in the developing world, attitudes towards them, and solutions for addressing them.

The Challenge of Noncommunicable Disease in Emerging Powers

with Yanzhong Huang, Rachel Nugent, Derek Yach, Jean-Paul Chretien
Profound changes in lifestyle, diets, and access to health care are taking place across the developing world. Higher income is commonly considered to lead to improved health, yet it also leads to increased incidence of noncommunicable diseases. In developing countries, these often affect working adults more than in developed nations. In this meeting, health experts offer analysis and recommendations regarding these trends.A A